Guillaume Baudry, Luca Monzo, Mark C. Petrie, Nicolas Girerd, Ileana L. Piña, Alexandre Mebazaa, Javed Butler, Leila Abid, Faiez Zannad, Harriette G. C. Van Spall
{"title":"Consistency of HFrEF treatment effect in underrepresented groups in randomized clinical trials","authors":"Guillaume Baudry, Luca Monzo, Mark C. Petrie, Nicolas Girerd, Ileana L. Piña, Alexandre Mebazaa, Javed Butler, Leila Abid, Faiez Zannad, Harriette G. C. Van Spall","doi":"10.1038/s44325-024-00028-4","DOIUrl":null,"url":null,"abstract":"Despite the established efficacy of heart failure (HF) guideline-directed medical therapies, implementation varies across demographic groups, including Black, Indigenous, and people of color, older adults, females, and those who are socioeconomically deprived. It reviews the largely consistent treatment effect of medical therapies across the demographic groups represented in trials. It makes arguments for broad implementation of therapies based on these data, while calling for more representative trials to improve research and health equity in HF.","PeriodicalId":501706,"journal":{"name":"npj Cardiovascular Health","volume":" ","pages":"1-11"},"PeriodicalIF":0.0000,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.nature.com/articles/s44325-024-00028-4.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"npj Cardiovascular Health","FirstCategoryId":"1085","ListUrlMain":"https://www.nature.com/articles/s44325-024-00028-4","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Despite the established efficacy of heart failure (HF) guideline-directed medical therapies, implementation varies across demographic groups, including Black, Indigenous, and people of color, older adults, females, and those who are socioeconomically deprived. It reviews the largely consistent treatment effect of medical therapies across the demographic groups represented in trials. It makes arguments for broad implementation of therapies based on these data, while calling for more representative trials to improve research and health equity in HF.